Jenna Philpott is a trainee healthcare and pharmaceutical reporter. Coming from a scientific background, Jenna has expertise in biochemistry, genetics and cancer science. Jenna previously wrote freelance articles focused on oncology and healthcare.
Proximie’s software development kit (SDK) will be used by surgeons, healthcare organisations and medical device companies to advance the field of surgery.
The FDA-approved 3D-printed bone graft has made its clinical debut in jaw surgeries performed in the US and Germany.
Philips has launched several devices at the RSNA as the company recovers from mass device recalls this year.
The full market release in the US comes after the FDA 510(K) cleared device was first used in April at the Southern California Orthopedic Institute.
Emergency room visits for post-myocardial infarction patients were down 27.5% after using the SmartHeart device.
Give your business an edge with our leading industry insights.
The findings match the accuracy of radiologists in detecting breast cancer when the AI threshold is appropriately set.
The deal involves upfront funding, milestone payments and royalties on approved products coming out from the collaboration.
The non-invasive Vivally device uses neuromodulation to block electric signals along nerves to the brain that encode urinary urges.
The commercial agreement includes licensing fees and additional payments in return for the exclusive rights to market Nerivio in several European countries.
FDA 510(k) clearance has been given to InMed AI’s NeuroShield imaging device, aiding physicians in diagnosing neurodegenerative diseases.